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616Objectives: Both partial and complete annuloplasty rings are used for mitral valve repair for patients with func-
tional mitral regurgitation (FMR). We sought to determine if recurrence of mitral regurgitation (MR) is affected
by the type of ring used.
Methods: Five hundred forty-eight patients diagnosed with FMR underwent mitral valve repair with ring
annuloplasty between 1998 and 2008 in our institution. Medical records were reviewed retrospectively
for clinical and echocardiographic data to determine the presence of recurrent MR (defined as moderate
or severe).
Results: Among 479 patients for whom postoperative echocardiographic data were available, recurrent MR
occurred less frequently in the complete versus partial ring group (20 of 209 [10%] vs 56 of 270 [21%] patients;
P¼ .001), despite lower preoperative ejection fractions in the complete ring group (median, 35%; interquartile
range, 25%-45% vs median, 40%; interquartile range, 30%-55%; P<.001). Kaplan-Meier analysis demon-
strated greater freedom from recurrent MR in the complete ring group (108 vs 103 months; P ¼ .001). Risk-
matched propensity analysis of 102 patients per group (area under the curve, 0.824; 95% confidence interval,
0.788-0.861; P< .001) also demonstrated that complete ring recipients had greater freedom from recurrent
MR than partial ring recipients by univariate analysis (7 [7%] vs 17 [17%] patients; P ¼ .049), and a trend
toward greater freedom by Kaplan-Meier analysis (110 vs 104 months; P ¼ .068).
Conclusions: The use of complete mitral annuloplasty rings provides improved freedom from recurrent MR in
patients with FMR. (J Thorac Cardiovasc Surg 2013;146:616-22)Functional mitral regurgitation (FMR) is a type of mitral re-
gurgitation (MR) that occurs despite structurally normal mi-
tral valve leaflets, usually in patients with advanced
ischemic or idiopathic dilated cardiomyopathy.1,2 FMR
carries a poor prognosis with medical treatment alone,
resulting in 1-year survival rates of 52% to 87% and
5-year survival rates of 22% to 54%.3-6
The pathophysiology of FMR is complex. As dilated
cardiomyopathy worsens, ongoing left ventricular remod-
eling and dilation are associated with subtle structural
changes to the mitral valve apparatus, including mitral
annular dilation, lateral displacement of the posterome-
dial papillary muscle, and tethering of the mitral valve
leaflets. Together, these changes prevent proper coapta-
tion of the mitral valve leaflets during systole, ultimately
resulting in retrograde flow across the valve. The annulare Division of Cardiac Surgery, Brigham and Women’s Hospital, Harvard
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The Journal of Thoracic and Cardiovascular Surgdilation component of these structural changes has been
the most widely recognized aspect of the pathophysiol-
ogy of FMR. As such, the intent of mitral ring annulo-
plasty in this setting is to reduce the size of the
annulus so that proper coaptation of the leaflets is re-
stored, thereby eliminating regurgitation. This approach
is effective in the acute correction of FMR in a majority
of patients, and has therefore been the primary surgical
method of treating FMR clinically. Unfortunately, it has
been associated with rates of recurrent MR as high as
15% to 30%.7-9
Currently, both partial (C-ring) and complete (O-ring)
annuloplasty rings are used for mitral annuloplasty in pa-
tients with FMR. Prior reports have not demonstrated any
difference in durability of repair between the 2.10,11
Accordingly, there are no clear principles that guide the
choice of 1 type of ring over another in the clinical
practice of most surgeons other than anecdotal
information about the superiority of 1 type of ring over
the other. A recent retrospective study12 showed that for pa-
tients with degenerative MR, the use of complete, semi-
rigid annuloplasty rings was associated with lower rates
of recurrent MR compared with partial flexible annulo-
plasty rings. To date, this has not been investigated specif-
ically in patients with FMR, in whom both the
pathophysiology of the MR itself and the operative ap-
proach are significantly different. We therefore sought toery c September 2013
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This study is a retrospective, nonrandomized review of all patients who
underwent mitral valve repair using undersized mitral ring annuloplasty as
the primary intervention for FMR between 1998 and 2008 at our institution.
The study was approved by the internal Institutional Review Board with
a waiver for patient consent.
Patients
A total of 548 patients between October 1998 and December 2008 who
underwent mitral valve repair using mitral ring annuloplasty without the
use of edge-to-edge Alfieri stitch repair for the diagnosis of FMR were
identified in the Society of Thoracic Surgeons database (version 2.52).
FMR was defined as the presence of all 3 of the following criteria: a docu-
mented diagnosis of ischemic or idiopathic dilated cardiomyopathy;MR by
echocardiography not attributable by echocardiographic criteria to degen-
erative disease; and intraoperative findings from the operative report de-
scribing the presence of normal, nondegenerative mitral valve leaflets.
Preoperative clinical data collected include the patient’s age, sex,
height, weight, calculated body surface area, preoperative New York Heart
Association Functional Class, ejection fraction and degree of MR by pre-
operative echocardiogram, presence of preoperative atrial fibrillation, dia-
betes mellitus, hypertension, chronic lung disease, chronic renal failure,
hyperlipidemia, stroke, peripheral vascular disease, preoperative intra-
aortic balloon pump requirement, and the etiology of FMR (ischemic or id-
iopathic). Left ventricular end-diastolic dimension index (LV EDD Index)
was calculated by dividing the measured LV EDD by the calculated patient
body surface area.
The primary end point was the incidence of recurrent MR, defined by
the presence of moderate-to-severe MR by echocardiography at any post-
operative time point within the study period. The final cohort of patients
was ultimately composed of 479 total patients for whom postoperative
echocardiographic data were available. Among these patients, 270 received
partial rings and 209 received complete rings.
Surgical Management
All patients underwent mitral valve procedures, with or without con-
comitant heart procedures, performed by 1 of 13 surgeons. Intraoperative
echocardiography was performed in all patients before and immediately
following mitral valve annuloplasty ring placement. Exposure was
provided by median sternotomy for most patients, except for 38 patients
(8%) in whom either minimally invasive thoracotomy or hemisternotomy
was performed. All procedures were performed with the use of mild sys-
temic hypothermic cardiopulmonary bypass with intermittent crystalloid
cardioplegia to provide myocardial protection. Exposure to the mitral ap-
paratus was achieved through a traditional left atrial incision along Sonder-
gaard’s groove. Patients received one of three types of partial rings or 1 of 5
types of complete rings. The choice of ring was left to the discretion of theThe Journal of Thoracic and Casurgeon at the time of operation. Of note, the Carbomedics Annuloflex ring
(Sulzer Carbomedics, Inc, Austin, Tex (division of Sulzer Medica) has the
capability of being implanted in partial or complete configuration and is
therefore represented in both groups. Rings were downsized in standard
fashion by choosing a ring 1 or 2 sizes smaller than predicted by measuring
the height of the anterior leaflet.
Follow-up
Postoperative echocardiographic and clinical data, including postopera-
tive complications andmortalitywere obtained from the Society of Thoracic
Surgeons and departmental databases, institutional electronic medical re-
cords, and query of the Social Security Death Index. The primary end point
for this study was the postoperative recurrence of MR, defined in this study
as either 3þ(moderate) or 4þ(severe) MR at any time point during the study
period. 30-day mortality was defined as mortality within 30 days regardless
of hospital discharge, whereas operative mortality was defined according
to the Society of Thoracic Surgeons definition (ie, mortality within 30
days and/or death before discharge from the index hospitalization).
Statistical Analysis
Categorical data are expressed as numbers and percentage, and contin-
uous data as means standard deviation or medians and interquartile range
for normally or non-normally distributed data. Categorical variables were
compared using the Fisher exact test. Continuous variables were compared
using the Student t test with the Levine test for homogeneity of variance or
Mann-Whitney U test as appropriate.
A risk-matched propensity analysis consisted of a logistic regression
analysis. Based on available literature, clinical expertise, patient character-
istics, and known operative differences, we selected factors contributing to
the likelihood of receiving a complete or partial ring. These were entered
into a multivariable forward stepwise logistic regression. Interactions
were examined, and the interaction variable between the surgeon and
year of surgery was included to control for differences in the patient comor-
bidity loads and techniques over time. Any variable significant at a P value
.15 was retained. The resulting adjusted predicted value for each patient
was calculated, and a 1:1 complete:partial ring match based on predicted
value (nearest thousandth place) was derived. Subsequent analyses were
performed on this cohort of 204 subjects (n ¼ 102 per group).
Enter-method Cox regression analysis of the unmatched cohort was per-
formed to evaluate if ring type was an independent variable for MR recur-
rence. Covariates with known associations with greater severity of disease
and for which complete data were available were included for analysis.
Survival was estimated by using Kaplan-Meier analyses. Statistical anal-
yses were performed with SPSS version 13.0 (2005; IBM, Armonk, NY).RESULTS
Overall Results
We limited the majority of our analyses to the 479 of 548
subjects with follow-up echocardiographic data available.
A responder bias analysis between these subjects and the
69 for whom we lacked postoperative echocardiographic
data showed no significant differences with respect to age,
sex, preoperative cardiac measures, operative times, or
concomitant procedures (data not shown).
Among 479 patients for whom postoperative echocardio-
graphic data were available, Table 1 shows that complete
ring recipients had significantly lower preoperative ejection
fractions and a higher proportion of patients requiring preoper-
ative intra-aortic balloon pump support compared with partial
ring recipients, but were similar with regard to all otherrdiovascular Surgery c Volume 146, Number 3 617
TABLE 1. Patient characteristics
Characteristic
Partial Complete
P value(n ¼ 270) (n ¼ 209)
Age (mean y  SD) 69.3  10.6 67.9  10.2 .13
Females 135 (50) 88 (42) .1
Body surface area
(mean m2  SD)
1.88  0.24 1.90  0.26 .48
Mitral regurgitation grade .85
2 1 (0.4) 0 (0)
3 130 (48) 104 (50)
4 139 (51) 105 (50)
NYHA Functional Class .34
I 31 (11) 24 (11)
II 88 (33) 56 (27)
III 120 (44) 96 (46)
IV 30 (11) 33 (16)
Etiology of FMR .45
Ischemic 165 (61) 135 (65)
Idiopathic 105 (39) 74 (35)
Ejection fraction
(median% [IQR])
40 (30-55) 35 (25-45) .001*
LV EDD ¼ Index
(mean cm/m2  SD)
3.1  0.7 3.2  0.6 .65
IABP support 14 (5) 24 (11) .02*
Atrial fibrillation 78 (29) 52 (25) .35
Diabetes mellitus 76 (28) 62 (30) .76
Hypertension 187 (70) 148 (71) .76
Chronic lung disease 49 (18) 42 (20) .64
Chronic renal failure 34 (13) 36 (17) .19
Hyperlipidemia 165 (61) 138 (66) .29
Stroke 21 (8) 19 (9) .92
Peripheral vascular disease 45 (17) 25 (12) .15
Continuous data are presented as mean  standard deviation (SD) for normally dis-
tributed data and as median and interquartile range for non-normally distributed data
as indicated above. Categorical data are presented as the number of patients (%) in
each category. NYHA, New York Heart Association; FMR, functional mitral regurgi-
tation; LV EDD Index, left ventricular end-diastolic diameter index (LV EDD normal-
ized to body surface area); IABP, Intra-aortic balloon pump (preoperative); IQR,
interquartile range. *Statistically significant.
TABLE 2. Operative data
Characteristic
Partial Complete
P value(n ¼ 270) (n ¼ 209)
Minimally invasive 26 (10) 12 (6) .13
CPB (mean min  SD) 148  63 188  69 .001*
Cross-clamp (mean min  SD) 105  50 129  52 .001*
Concomitant procedures
CABG 160 (59) 126 (60) .85
Aortic valve 55 (20) 29 (14)  .07
Tricuspid valve 47 (17) 64 (31) .001*
Pulmonic valve 1 (0.4) 2 (1) .58
Mitral procedures
Commissuroplasty 1 (0.4) 5 (2) .09
Cleft repair (anterior leaflet) 1 (0.4) 0 (0) 1
Cleft repair (posterior leaflet) 5 (2) 3 (1) 1
Anterior chordal release 1 (0.4) 1 (0.5) 1
Posterior leaflet resection 0 (0) 1 (0.5) .44
Ring type
Carbomedics Annuloflexy 66 (24) 69 (33) N/A
C-G Future Bandz 6 (2.2) 0 (0) N/A
Cosgrove-Edwardsx 198 (73) 0 (0) N/A
Carpentier-Edwards Physiox 0 (0) 96 (46) N/A
Geoformx 0 (0) 31 (15) N/A
Carbomedics Memo 3Dy 0 (0) 8 (4) N/A
St Jude Saddlejj 0 (0) 5 (2) N/A
Ring size (mean mm  SD) 28.6  2.3 28.4  2.3 .24
Continuous data are presented as mean standard deviation (SD) as indicated above.
All categorical data are presented as numbers of patients (%) in each. CPB, Cardio-
pulmonary bypass; C-G Future Band, Colvin-Galloway Future Band; N/A, not appli-
cable; CABG, coronary artery bypass graft. *Statistically significant. ySorin Group,
Milan, Italy. zMedtronic Inc, Minneapolis, Minn. xEdwards Lifesciences, Irvine, Ca-
lif. jjSt Jude Medical, Inc, St Paul, Minn.
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dex, and ring size (which was in accordance with median ring
sizes observed in similar studies of annuloplasty for FMR7).
Intraoperatively, complete rings were associated with
significantly longer perfusion times (median 180 vs 139
minutes for partial rings; P<.001) and cross-clamp times
(median 120 vs 97 minutes; P<.001). Subjects receiving
complete rings were significantly more likely to have
concomitant tricuspid valve procedures, which may partly
contribute to the longer operative times (Table 2). The per-
centage of patients receiving complete rings by year begin-
ning in 1998 was 0%, 50%, 67%, 58%, 32%, 21%, 24%,
34%, 57%, 71%, and 82%.
Postoperatively, for the primary end point, recurrent MR
occurred more frequently in patients who received partial
rings compared with those who received complete rings
(56 of 270 patients [21%] vs 20 of 209 patients [10%];618 The Journal of Thoracic and Cardiovascular SurgP ¼ .001). The proportion of patients with recurrence oc-
curring within the first 6 months postoperatively was similar
between groups (19 of 56 partial ring recipients [34%], 6 of
20 complete ring recipients [30%]; P ¼ 1.0]. There was
a strong trend towards a higher mean time to echocardio-
graphic follow-up in the partial compared with the complete
ring group (17.7  25.0 vs 13.5  20.0 months; P ¼ .06).
Median freedom from recurrent MRwas longer in complete
ring recipients compared with partial ring recipients by sur-
vival estimation (108 vs 103 months; P ¼ .001 based on
Kaplan-Meier analysis (Figure 1, A). However, there was
no difference in survival between the two groups with a me-
dian survival of 101months in the partial ring group and 103
months in the complete ring group (P ¼ .85 based on
Kaplan-Meier analysis) (Figure 1, B).
Because echocardiographic data were missing from 12%
of the initial cohort of 548 patients, we performed Kaplan-
Meier analysis of freedom from recurrent MR considering
the study end point as indeterminate for the recurrence of
MR and found that complete ring group retained its longer
period of freedom from MR compared with the partial ring
group (134 vs 110 months; P ¼ .008) (data not shown).
There were nomajor differences in the major categories of
postoperative complications between the partial ring groupery c September 2013
FIGURE 1. Kaplan-Meier analysis: Freedom from recurrent mitral regur-
gitation (MR) and survival. A, Freedom from recurrent MR in unmatched
cohorts. There were 270 subjects in the partial ring group (black line); and
209 subjects in the complete ring group (gray dash). B, Survival curves in
unmatched cohorts. There were 270 in the partial ring group (black line);
and 209 subjects in the complete ring group (gray dash). C, Freedom
from recurrent MR in risk-matched cohorts (n ¼ 102 patients per group).
Partial ring group (black line); complete ring group (gray dash).
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Dversus the complete ring group by univariate analysis, includ-
ing 30-day mortality (1.0% vs 1.4%; P ¼ .55), operative
mortality (4.4% vs 2.4%; P¼ .32), new onset postoperative
atrial fibrillation (22% vs 25%; P ¼ .45), multisystem
organ failure (0.7% vs 1%;P¼ 1.0), gastrointestinal compli-
cations (63% vs 4.3%; P ¼ .42), cardiac arrest (2.6% vs
2.4%; P ¼ 1.0), acute renal failure (7.4% vs 8.1%;
P ¼ .86), pneumonia (4.1% vs 2.9%; P ¼ .62), pulmonary
embolism (0.4% vs 0%; P ¼ 1.0), stroke (4.1% vs 4.8%;
P ¼ .89), and sepsis (4.1% vs 2.4%; P ¼ .44). There was
no difference in the mean change in ejection fraction (2%
 14% in the complete ring group and 2% 13% in the par-
tial ring group; P ¼ .94).
Risk-Matched Propensity Analyses
Using themethods described above, we developed amod-
erately robust model to test the hypothesis that the type of
ring can predict the rate of MR recurrence (area under
the curve, 0.824; 95% confidence interval [CI], 0.788-
0.861; P< .001). We were able to match 102 complete
ring subjects per cohort (complete vs partial rings).
Table 3 shows the characteristics and outcomes of the
matched cohort. Although the groups were substantially
similar, the trend toward longer cross-clamp and perfu-
sion times in the complete ring group remained, but it
was not statistically significant. On the primary end
point, patients in the partial ring group had a significantly
higher risk of developing recurrent MR during the study
period (17 [17%] vs 7 [7%] patients; odds ratio [OR],
2.714; 95% CI, 1.074-6.863; P ¼ .049). Kaplan-Meier
analysis of freedom from recurrent MR showed a trend
toward improved freedom from recurrent MR in the com-
plete ring group (110 vs 104 months; P ¼ .068)
(Figure 1, C).
Cox Regression Analysis
Among the covariates tested, the strongest predictors for
MR recurrence were the use of partial rings (OR, 2.001;
95% CI, 1.164-3.441; P ¼ .012), preoperative MR grade
4 (OR, 2.081; 95% CI, 1.243-3.485; P ¼ .005), and previ-
ous valve procedures (OR, 1.031; 95% CI, 0.970-1.761;
P¼ .063). All other tested variables were nonsignificant, in-
cluding age (P ¼ .844), being a woman (P ¼ .968), preop-
erative ejection fraction (P ¼ .687), New York Heart
Association Functional Class IV (P ¼ .275), concomitant
coronary artery bypass graft surgery (P¼ .703), and cardio-
pulmonary bypass time (P ¼ .230).
DISCUSSION
Recurrence of MR
The major conclusion of this retrospective review com-
paring the use of partial to complete ring mitral annulo-
plasty for patients with FMR is that despite evidence to
suggest that patients receiving complete rings had greaterrdiovascular Surgery c Volume 146, Number 3 619
TABLE 3. Characteristics and postoperative outcomes for risk-
matched propensity group analysis
Characteristic
Partial Complete
P value(n ¼ 102) (n ¼ 102)
Preoperative
Age (mean y  SD) 68.6  11.0 68.4  10.2 .87
Women 53 (52) 41 (40) .12
Body surface area
(mean m2  SD)
1.9  0.2 1.9  0.2 .23
Diabetes mellitus 26 (26) 31 (30) .53
Chronic renal failure 14 (14) 16 (16) .84
Preoperative creatinine
(mean  SD)
1.4  0.9 1.3  0.6 .38
Hypercholesterolemia 70 (69) 70 (69) 1.0
Stroke 8 (8) 10 (10) .81
Peripheral vascular disease 15 (15) 12 (12) .68
Atrial fibrillation 27 (27) 25 (25) .87
Myocardial infarction 45 (44) 44 (43) 1.0
NYHA Functional Class
I 11 (11) 12 (12) 1.0
II 33 (32) 30 (29) .76
III 45 (44) 45 (44) 1.0
IV 13 (13) 15 (15) .84
Etiology of FMR
Ischemic 66 (65) 63 (62) .77
Idiopathic 36 (35) 39 (38) .77
Ejection fraction
(median% [IQR])
35 (25-50) 35 (25-50) .79
Intraoperative
Emergent procedure 6 (6) 3 (3) .50
IABP support 20 (20) 19 (19) 1.0
Concomitant procedures
CABG 62 (61) 63 (62) 1.0
Aortic valve 19 (19) 17 (17) .86
Tricuspid valve 25 (25) 22 (22) .74
CPB (median min [IQR]) 153 (111-207) 173 (132-218) .12
Cross-clamp (median
min [IQR])
100 (68-137) 119 (75-160) .083
Postoperative
Reoperation for bleed 1 (1) 4 (4) .62
Permanent stroke 6 (6) 3 (3) .50
Pulmonary embolism 1 (1) 0 (0) 1.0
New onset renal failure 10 (10) 11 (11) 1.0
Coagulopathy 8 (8) 4 (4) .54
New onset atrial fibrillation 47 (46) 42 (41) .57
Operative mortality* 8 (8) 4 (4) .54
Length of stay
(median d [IQR])
10 (7-18) 10 (8-15) .91
Ejection fraction
(median% [IQR])
40 (30-55) 40 (30-50) .25
Recurrence of MR (3þor 4þ) 17 (17) 7 (7) .049
Categorical data are presented as the number of patients (%) in each. Non-normally
distributed continuous data are presented as the median (IQR). Normally distributed
continuous data are presented as means  SD. SD, Standard deviation; NYHA, New
York Heart Association; FMR, functional mitral regurgitation; IQR, interquartile
range; IABP, intra-aortic balloon pump; CABG, coronary artery bypass graft; CPB,
cardiopulmonary bypass; AF, atrial fibrillation; MR, mitral regurgitation. *Based
on The Society of Thoracic Surgeons definition: 30-day mortality plus mortality
before hospital discharge.
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Drisk factors for ongoing deterioration of cardiac function (as
evidenced by lower left ventricular ejection fraction, greater
prevalence of preoperative intra-aortic balloon pump sup-
port, more frequent need for concomitant tricuspid valve
procedures, and longer bypass and cross-clamp times), the
use of complete mitral annuloplasty rings was associated
with greater freedom from the onset of recurrent moderate
to severe MR than the use of partial rings. This
relationship was demonstrated in unmatched cohorts by
univariate analysis demonstrating roughly a twofold greater
risk of recurrent MR in complete ring recipients, with the
caveat that the partial ring group had a trend toward longer
mean time to postoperative echocardiographic follow-up
than the complete ring group, which may present follow-
up bias in favor of improved freedom from recurrent MR
in the complete ring group. To overcome this limitation of
our study, we performed Kaplan-Meier analysis of the
unmatched cohort, univariate analysis of the propensity-
matched groups, and Cox regression multivariate analysis
of the unmatched cohort; all 3 analyses demonstrated sig-
nificantly higher risk of MR recurrence in patients receiving
partial rings compared with complete rings. In addition,
Kaplan-Meier analysis of the risk-matched groups showed
a strong trend toward longer freedom from recurrent MR
in the complete ring group.
The most well-accepted preoperative factors that specif-
ically predict a higher rate of recurrence of MR after annu-
loplasty include increased preoperative left ventricle
dilation with LV EDD>65 mm,13 higher severity of preop-
erative MR,7,14 and lower preoperative left ventricular
ejection fraction.7,14 In both unmatched and matched
cohort analyses in our study, these 3 factors were either
equivalent between groups or, as in the case of left
ventricular ejection fraction, which was significantly
lower in the unmatched complete ring cohort, actually
favored improved freedom from recurrent MR in the
partial ring group. Despite this, partial ring recipients had
higher rates of recurrence.Mechanistic Implications
The primary structural difference between partial and
complete rings is the ability of complete rings to maintain
a fixed annular diameter as well as a fixed intertrigonal
and septal-lateral distance regardless of ongoing geometric
changes to other portions of the mitral valve apparatus. As
such, the results of our study suggest that the higher rate of
recurrent MR in the partial ring group is due, at least in part,
to the overall effect that ongoing annular dilation of the an-
terior portion of the annulus (which is left unsupported in
partial ring recipients) has in altering the overall geometry
of the mitral apparatus. Classic teaching has been that
only the posterior muscular portion of the mitral annulus di-
lates in FMR, but more recent work has demonstrated bothery c September 2013
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and myxomatous MR15 as well as in ovine models of
FMR16 that the anterior fibrous portion of the mitral annulus
also dilates. In addition, partial rings may be inferior in their
ability to maintain a fixed septal-lateral distance, a measure
that has been shown in experimental studies to be both nec-
essary and sufficient to restore mitral competency.17,18
Although our study was not designed to measure changes
in the length of the anterior portion of the annular
circumference nor the intertrigonal and septal-lateral dis-
tances, our findings suggest that the anchoring effect of 1
trigone to the other as well as the relative stability of the
septal-lateral distance inherent in the use of complete rings
is likely the mechanism by which complete ring use imparts
significant benefit to the durability of repair. Meanwhile, it
should be noted that 10% of the unmatched cohort and 7%
of matched cohort of complete ring recipients still devel-
oped MR recurrence during the study period, suggesting,
in accordance with other studies, that factors other than on-
going anterior annular dilation such as displacement of the
posterior papillary muscle19 and tethering of the poste-
rior20,21 or anterior22-24 leaflets, are likely to have been
the mechanism for recurrence in patients in whom the
annulus can be thought to have been more durably
remodeled by the ring. Further studies are needed to test
this hypothesis discretely.
Survival
Similar to other studies showingno affect on survival based
on ring type,7,14 our study also demonstrated no survival
difference between complete and partial ring recipients.
True survival in the may actually be better in the complete
ring group, but this effect may have been offset by the
higher overall cardiovascular risk in this group, which may,
in turn, be a result of a progressive institution-wide trend to-
ward repairing MR in higher-risk patients.25 Another possi-
bility is that the true difference in survival, if any, may be
too small to detect given the number of patients in our study,
in which case, the difference would essentially be clinically
insignificant. Either way, it is clear there is no overwhelming
survival benefit to using a complete ring demonstrated in this
study. In addition, it is not possible to determine with cur-
rently available statistical methods whether or not recurrence
is directly related to survival.
Study Limitations
In addition to the general limitations inherent in retro-
spective series, the primary limitation of our study was
the reliance on postoperative echocardiograms to detect
the occurrence of the primary end point. Routine predis-
charge echocardiograms are not performed universally at
our institution, and are often only obtained in the setting
of a specific clinical indication at the discretion of the sur-
geon and/or cardiologist. Therefore, there was wideThe Journal of Thoracic and Cavariability in the time intervals for both the first and any
subsequent postoperative echocardiograms. This may also
account for the relatively late onset of MR recurrence in
this study compared with other studies. In addition, echo-
cardiograms were not re-reviewed to measure advanced
echocardiographic measurements, including tenting height,
tenting area, and tethering angles. Meanwhile, not only was
there a significant difference in the overall echocardio-
graphic follow-up interval between the unmatched groups,
but also 12% of the original cohort of patients who met
study criteria did not have any postoperative echocardio-
grams in our records at all. Although the influence of these
2 factors is difficult to predict, as noted above, a responder
bias analysis showed no significant differences between
these patients and those who did have postoperative echo-
cardiographic data. In addition, Kaplan-Meier analysis
has the ability to partially overcome this limitation, but
our study still remains less conclusive than a similarly
designed prospective trial.
Furthermore, as a nonrandomized study, there were sig-
nificant differences in preoperative characteristics. As men-
tioned above, none of these differences favored improved
outcomes in the complete ring group, and MR recurrence
rates were higher in the partial ring group. We attempted
to control for these differences using a risk-matched pro-
pensity model as well as Cox regression analysis, and found
that the improved freedom from recurrent MR in the
complete ring group retained significance in both of these
analyses.
Clinical Implications
The observations in our study are in accordance with
what many surgeons already believe anecdotally or have de-
termined formally from their own clinical experience,12,26
and as such, several, but not all surgeons in our institution
have shifted their practice from using partial rings to full
rings for functional MR.
In the past, the primary argument in favor of the use partial
rings included the suggestion that the risk of systolic anterior
motion (SAM) is higher with complete rings27 due to ante-
rior displacement of the leaflet coaptation point, secondary
to excessive height or redundant tissue of the posterior leaf-
let.12 However, not only has this never been clearly demon-
strated, the concern about SAM applies primarily in patients
with myxomatous disease in whom, mechanistically speak-
ing, the risk of SAM is higher, and not in patients with FMR
in whom the leaflets are structurally normal and not redun-
dant. Indeed, owing to the nonmyxomatous nature of our pa-
tient population, none of the patients in our study received
a concomitant Alfieri stitch repair or any type of leaflet re-
section procedure. Given that the primary perceived disad-
vantage of using a complete ring is that of a higher
theoretical risk of SAM, we believe that the improved free-
dom from recurrent MR demonstrated by our study formsrdiovascular Surgery c Volume 146, Number 3 621
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Da compelling argument in favor of the use of complete rings
in all patients undergoing annuloplasty for FMR.
CONCLUSIONS
Compared to the use of partial rings, the use of complete
rings for undersized mitral valve annuloplasty provides im-
proved freedom from recurrent MR in patients undergoing
mitral valve repair for FMR, but without any definite affect
on patient survival.
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